These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 330168)

  • 1. Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
    Pouleur H; Chaudron JM; Reyns P
    Eur J Cardiol; 1977 Jul; 5(5):397-404. PubMed ID: 330168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the anti-arrhythmic effects of propafenone and aprindine in the treatment of refractory chronic ventricular arrhythmias. A randomized double-blind crossover study controlled with placebo].
    Purcaro A; Amici R; Ciampani N; Costantini C; Mocchegiani R; Pigini G
    G Ital Cardiol; 1983; 13(6):444-50. PubMed ID: 6357929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
    Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH
    J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
    Hillson RM; Boyd E; Cunningham J
    J Int Med Res; 1980; 8(5):314-20. PubMed ID: 6998791
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of a study to evaluate drug therapy of serious ventricular rhythm disturbances after an acute myocardial infarction.
    Hagemeijer F; Glaser B; van Durme JP; Bogaert M
    Eur J Cardiol; 1977 Dec; 6(4):299-310. PubMed ID: 338307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
    Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH
    Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprophylaxis of arrhythmias with oral disopyramide in acute myocardial infarction.
    Nigam P; Khan S; Singh R; Kapoor KK; Kumar A; Gupta AK
    J Assoc Physicians India; 1983 Dec; 31(12):759-62. PubMed ID: 6370949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
    Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
    Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of aprindine and disopyramide on reperfusion-induced arrhythmias and cardiac function in isolated rat hearts.
    Iwasaki S; Araki H; Yamakawa T; Nishi K; Miyauchi Y
    Arch Int Pharmacodyn Ther; 1989; 300():174-85. PubMed ID: 2619422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
    Kumana CR; Rambihar VS; Willis K; Gupta RN; Tanser PH; Cairns JA; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):529-37. PubMed ID: 6753888
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders].
    Leclercq JF; Attuel P; Milosevic D; Rosengarten MD; Coumel P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):923-30. PubMed ID: 6793009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aprindine treatment of ventricular arrhythmias].
    Sellier P
    Coeur Med Interne; 1980; 19(1):67-71. PubMed ID: 7379481
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of disopyramide after myocardial infarction.
    Jones MB
    Bristol Med Chir J; 1976; 91(339-340):12. PubMed ID: 802388
    [No Abstract]   [Full Text] [Related]  

  • 18. Aprindine in premature ventricular contractions post myocardial infarction.
    Lessem J
    Chin Med J (Engl); 1981 Aug; 94(8):518-22. PubMed ID: 6168438
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
    Zainal N; Carmichael DJ; Griffiths JW; Besterman EM; Kidner PH; Gillham AD; Summers GD
    Lancet; 1977 Oct; 2(8044):887-9. PubMed ID: 72237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW; Bonagura JD
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.